标题
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
作者
关键词
-
出版物
Cell and Bioscience
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-10
DOI
10.1186/s13578-020-00396-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- piRNAs: biogenesis and their potential roles in cancer
- (2020) Binghong Guo et al. CANCER AND METASTASIS REVIEWS
- Microsatellite instability: a review of what the oncologist should know
- (2020) Kai Li et al. Cancer Cell International
- GWAS in cancer: progress and challenges
- (2020) Baiqiang Liang et al. MOLECULAR GENETICS AND GENOMICS
- RNA-based pharmacotherapy for tumors: From bench to clinic and back
- (2020) Xiangping Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer immunotherapy: Pros, cons and beyond
- (2020) Shuzhen Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression
- (2019) Russell E. Ericksen et al. Cell Metabolism
- Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: 1997-2016
- (2019) Pierluca Piselli et al. INTERNATIONAL JOURNAL OF CANCER
- The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2
- (2019) Joanna R. Kovalski et al. MOLECULAR CELL
- Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma
- (2019) Yixin Yang et al. Cell Death & Disease
- GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway
- (2019) Yizhou Yao et al. BIOMEDICINE & PHARMACOTHERAPY
- IL‐8 protects prostate cancer cells from GSK‐3β‐induced oxidative stress by activating the mTOR signaling pathway
- (2019) Yi Sun et al. PROSTATE
- mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment
- (2019) Yu-Li Chen et al. Cancers
- YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
- (2019) Yuan Zhou et al. Cancer Cell International
- PTEN expression and mutations in TSC1 , TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma
- (2019) Juan M. Roldan‐Romero et al. INTERNATIONAL JOURNAL OF CANCER
- The single-cell sequencing: new developments and medical applications
- (2019) Xiaoning Tang et al. Cell and Bioscience
- Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE−/− mice
- (2019) Zhu Wang et al. Cell and Bioscience
- Is Dual mTORC1 and mTORC2 Therapeutic Blockade Clinically Feasible in Cancer?
- (2019) Nisha Unni et al. JAMA Oncology
- Two novel TSC2 mutations in renal epithelioid angiomyolipoma sensitive to everolimus
- (2019) Tao Wang et al. CANCER BIOLOGY & THERAPY
- Transcriptome analysis reveals an important candidate gene involved in both nodal metastasis and prognosis in lung adenocarcinoma
- (2019) Xiao Zhu et al. Cell and Bioscience
- Transcriptional regulation in model organisms: recent progress and clinical implications
- (2019) Jiaqi Tang et al. Open Biology
- The cancer exosomes: Clinical implications, applications and challenges
- (2019) Zhenye Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Circular RNAs: The star molecules in cancer
- (2019) Jianhong Liu et al. MOLECULAR ASPECTS OF MEDICINE
- Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
- (2018) Glenn J. Hanna et al. CLINICAL CANCER RESEARCH
- A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
- (2018) Johanna C. Bendell et al. CLINICAL CANCER RESEARCH
- Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
- (2018) Joseph J. Caumanns et al. CLINICAL CANCER RESEARCH
- Predictive biomarkers of endometrial cancer response: Results from NRG Oncology/Gynecologic Oncology Group study 86P
- (2018) D.A. Levine et al. GYNECOLOGIC ONCOLOGY
- Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma
- (2018) Hong Zhang et al. HEPATOLOGY
- Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations
- (2018) Ye-Lim Park et al. INTERNATIONAL JOURNAL OF CANCER
- Biallelic TSC2 Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to Temsirolimus
- (2018) Pablo Maroto et al. Journal of the National Comprehensive Cancer Network
- The mTOR–S6K pathway links growth signalling to DNA damage response by targeting RNF168
- (2018) Xiaoduo Xie et al. NATURE CELL BIOLOGY
- mTOR Inhibition via Displacement of Phosphatidic Acid Induces Enhanced Cytotoxicity Specifically in Cancer Cells
- (2018) Tra-Ly Nguyen et al. CANCER RESEARCH
- Downregulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis
- (2018) Ting Tao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ubiquitination of Rheb governs growth factor-induced mTORC1 activation
- (2018) Lu Deng et al. CELL RESEARCH
- Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function
- (2018) Fangjie Wang et al. Nature Communications
- UCP2 inhibition induces ROS/Akt/mTOR axis: Role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism
- (2017) Ilaria Dando et al. FREE RADICAL BIOLOGY AND MEDICINE
- Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells
- (2017) Katharina Essig et al. IMMUNITY
- Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors
- (2017) Shiraj Sen et al. JNCI-Journal of the National Cancer Institute
- mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment
- (2017) Melissa A. Orr-Asman et al. MOLECULAR CANCER THERAPEUTICS
- TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling
- (2017) Bin Wang et al. NATURE
- mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy
- (2017) Kara N. Goldman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth
- (2017) Chiara Di Malta et al. SCIENCE
- Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade
- (2017) Kei Ishibashi et al. Oncotarget
- Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors
- (2017) Shiraj Sen et al. JNCI-Journal of the National Cancer Institute
- Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
- (2016) D. J. Kwiatkowski et al. CLINICAL CANCER RESEARCH
- TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication
- (2016) Daniel W H Ho et al. GUT
- Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma
- (2016) Agnieszka Korfel et al. JOURNAL OF CLINICAL ONCOLOGY
- Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
- (2016) Vanessa S. Rodrik-Outmezguine et al. NATURE
- MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma
- (2015) S. Mohan et al. CLINICAL CANCER RESEARCH
- mTORC2 promotes cell survival through c-Myc–dependent up-regulation of E2F1
- (2015) Zhipeng Zou et al. JOURNAL OF CELL BIOLOGY
- A Novel Dual AMPK Activator/mTOR Inhibitor Inhibits Thyroid Cancer Cell Growth
- (2015) Robert L. Plews et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
- (2015) Kristen N. Pollizzi et al. JOURNAL OF CLINICAL INVESTIGATION
- Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
- (2015) Robert J Motzer et al. LANCET ONCOLOGY
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP
- (2015) S J H Ricoult et al. ONCOGENE
- Targeting mTOR dependency in pancreatic cancer
- (2014) Douglas C Morran et al. GUT
- HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer
- (2014) Si-Meng Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer
- (2014) Hui Jun Lim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- 9q33.3, A Stress-Related Chromosome Region, Contributes to Reducing Lung Squamous Cell Carcinoma Risk
- (2014) Qin Xiao et al. Journal of Thoracic Oncology
- Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma
- (2014) WENMIN HOU et al. Oncology Letters
- The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma
- (2013) Xiao Zhu et al. CARCINOGENESIS
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- An Intronic Polymorphism in GRP78 Improves Chemotherapeutic Prediction in Non-small Cell Lung Cancer
- (2011) Xiao Zhu et al. CHEST
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Dissecting the role of mTOR: Lessons from mTOR inhibitors
- (2009) Ryan J.O. Dowling et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- TOR-dependent control of autophagy: biting the hand that feeds
- (2009) Thomas P Neufeld CURRENT OPINION IN CELL BIOLOGY
- Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9
- (2009) Jing-song Chen et al. HEPATOLOGY RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started